Line 51: |
Line 51: |
| | | | | |
| |- | | |- |
− | |Example||Example||Example||Example | + | |Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement of PDGFRA, PDGFRB or FGFR1, or with PCM1-JAK2||'''''Overview'''''|| ||FQR |
| | | | | |
| |- | | |- |
− | |Example||Example||Example||Example | + | |Myeloid/Lymphoid Neoplasms with PDGFRA Rearrangement||Disease|| ||FQR |
| | | | | |
| |- | | |- |
− | |Example||Example||Example||Example | + | |Myeloid/Lymphoid Neoplasms with PDGFRB Rearrangement||Disease|| ||FQR |
| | | | | |
| |- | | |- |
− | |Example||Example||Example||Example | + | |Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement||Disease|| ||FQR |
| | | | | |
| |- | | |- |
− | |Example||Example||Example||Example | + | |Myeloid/Lymphoid Neoplasms with PCM1-JAK2||Disease|| ||FQR |
| | | | | |
| |- | | |- |